TNF Type-I Receptor Inhibitor, R-7050 Attenuates Acute Kidney Injury in a Mouse Model of Crush Syndrome

DOI: 10.4236/pp.2018.912043, PP. 547-558

Keywords: AKI, Hyperkalemia, IL-6, Rhabdomyolysis, TNF-α

Full-Text   Cite this paper   Add to My Lib

Abstract:

Crush syndrome (CS) is caused by severe and extensive muscular skeletal damages, and acute kidney injury (AKI) with hyperkalemia is one of the most lethal factors of this syndrome. Especially under natural disasters of earthquake, many persons die due to AKI and hyperkalemia-induced cardiac arrest, but there has been no pathogenesis-based drugs for preventing CS-induced AKI. Pro-inflammatory cytokines, such as TNF-α and IL-6, play a critical role for induction of AKI during CS development. Glycerol-injected mice are used as an experimental tool for reflecting pathological events of human CS. Using this popular model, we provide evidence to show that TNF type-I receptor (TNFR1) inhibitor, R-7050 significantly attenuates the onset of AKI after the muscular destruction. In this process, R-7050 treatment suppressed the NF-κB activation in the affected kidney, and this was associated with a decrease in blood IL-6, a downstream target of NF-κB. As a result, renal tubular apoptosis became milder in the R-7050-treated CS mice. These findings suggest that induction of IL-6 via sequential events of TNF-α à TNFR1 à NF-κB is contributable for renal tubular apoptosis, a histological hallmark of AKI. Thus, TNFR1-selective inhibition can be a pharmacological strategy to attenuate the onset of AKI immediately after the clinical manifestation of rhabdomyolysis.

References

[1]	Bosch, X., Poch, E. and Grau, J.M. (2009) Rhabdomyolysis and Acute Kidney Injury. New England Journal of Medicine, 361, 62-72. https://doi.org/10.1056/NEJMra0801327
[2]	Chavez, L.O., Leon, M., Einav, S. and Varon, J. (2016) Beyond Muscle Destruction: A Systematic Review of Rhabdomyolysis for Clinical Practice. Critical Care, 20, 135. https://doi.org/10.1186/s13054-016-1314-5
[3]	Tanaka, H., Oda, J., Iwai, A., et al. (1999) Morbidity and Mortality of Hospitalized Patients after the 1995 Hanshin-Awaji Earthquake. American Journal of Emergency Medicine, 17, 186-191. https://doi.org/10.1016/S0735-6757(99)90059-1
[4]	Zhang, L., Fu, P., Wang, L., et al. (2012) The Clinical Features and Outcome of Crush Patients with Acute Kidney Injury after the Wenchuan Earthquake: Differences between Elderly and Younger Adults. Injury, 43, 1470-1475. https://doi.org/10.1016/j.injury.2010.11.036
[5]	Yasuda, H., Yuen, P.S., Hu, X., et al. (2012) Protective Effect of Infliximab on Ischemia Reperfusion-Induced Damage in Rat Kidney. Renal Failure, 34, 1144-1149. https://doi.org/10.3109/0886022X.2012.717490
[6]	Wan, B., Hao, L., Qiu, Y., et al. (2006) Blocking Tumor Necrosis Factor-α Inhibits Folic Acid-Induced Acute Renal Failure. Experimental Molecular Pathology, 81, 211-216. https://doi.org/10.1016/j.yexmp.2006.02.005
[7]	Zhang, B., Ramesh, G., Norbury, C.C. and Reeves, W.B. (2007) Cisplatin-Induced Nephrotoxicity Is Mediated by Tumor Necrosis Factor-α Produced by Renal Parenchymal Cells. Kidney International, 72, 37-44. https://doi.org/10.1038/sj.ki.5002242
[8]	Shulman, L.M., Yuhas, Y., Frolkis, I., et al. (1993) Glycerol-Induced ARF in Rats Is Mediated by Tumor Necrosis Factor-α. Kidney International, 43, 1397-1401. https://doi.org/10.1038/ki.1993.196
[9]	Cabal-Hierro, L. and Lazo, P.S. (2012) Signal Transduction by Tumor Necrosis Factor Receptors. Cellular Signalling, 24, 1297-1305. https://doi.org/10.1016/j.cellsig.2012.02.006
[10]	Speeckaert, M.M., Speeckaert, R., Laute, M., et al. (2012) Tumor Necrosis Factor Receptors: Biology and Therapeutic Potential in Kidney Diseases. American Journal of Nephrology, 36, 261-270. https://doi.org/10.1159/000342333
[11]	Schiaffino, S., Pereira, M.G., Ciciliot, S. and Rovere-Querini, P. (2017) Regulatory T Cells and Skeletal Muscle Regeneration. FEBS Journal, 284, 517-524. https://doi.org/10.1111/febs.13827
[12]	Alikhan, M.A., Huynh, M., Kitching, A.R. and Ooi, J.D. (2018) Regulatory T Cells in Renal Disease. Clinical Translational Immunology, 7, e1004. https://doi.org/10.1002/cti2.1004
[13]	Salomon, B.L., Leclerc, M., Tosello, J., et al. (2018) Tumor Necrosis Factor-α and Regulatory T Cells in Oncoimmunology. Front Immunology, 9, 444. https://doi.org/10.3389/fimmu.2018.00444
[14]	Shustin, L., Wald, H. and Popovtzer, M.M. (1998) Role of Down-Regulated CHIF mRNA in the Pathophysiology of Hyperkalemia of Acute Tubular Necrosis. American Journal of Kidney Disease, 32, 600-604. https://doi.org/10.1016/S0272-6386(98)70023-X
[15]	Mizuno, S. and Horikawa, Y. (2016) Up-Regulation of Local TGF-β Contributes to a Decrease in Renal Tubular Na+-K+ ATPase and Hyperkalemia in a Mouse Model of Crush Syndrome. Pharmacology and Pharmacy, 7, 481-492. https://doi.org/10.4236/pp.2016.712054
[16]	Gururaja, T.L., Yung, S., Ding, R., et al. (2007) A Class of Small Molecules That Inhibit TNFα-induced Survival and Death Pathways via Prevention of Interactions between TNFαRI, TRADD, and RIP1. ChemBiolology, 14, 1105-1118.
[17]	Mizuno, S. and Nakamura, T. (2005) Prevention of Neutrophil Extravasation by Hepatocyte Growth Factor Leads to Attenuations of Tubular Apoptosis and Renal Dysfunction in Mouse Ischemic Kidneys. American Journal of Pathology, 166, 1895-905. https://doi.org/10.1016/S0002-9440(10)62498-4
[18]	Mizuno, S., Kurosawa, T., Matsumoto, K., et al. (1998) Hepatocyte Growth Factor Prevents Renal Fibrosis and Dysfunction in a Mouse Model of Chronic Renal Disease. Journal of Clinical Investigation, 101, 1827-1834. https://doi.org/10.1172/JCI1709
[19]	Kamimoto, M., Mizuno, S. and Nakamura, T. (2009) Reciprocal Regulation of IL-6 and IL-10 Balance by HGF via Recruitment of Heme Oxygenase-1 in Macrophages for Attenuation of Liver Injury in a Mouse Model of Endotoxemia. International Journal of Molecular Medicine, 24, 161-70.
[20]	King, M.D., Alleyne, C.H. Jr. and Dhandapani, K.M. (2013) TNF-α Receptor Antagonist, R-7050, Improves Neurological Outcomes Following Intracerebral Hemorrhage in Mice. Neuroscience Letter, 542, 92-96. https://doi.org/10.1016/j.neulet.2013.02.051
[21]	Scharman, E.J. and Troutman, W.G. (2013) Prevention of Kidney Injury Following Rhabdomyolysis: A Systematic Review. Annual Pharmacotherapy, 47, 90-105. https://doi.org/10.1345/aph.1R215
[22]	Jones, S.A., Fraser, D.J., Fielding, C.A. and Jones, G.W. (2015) Interleukin-6 in Renal Disease and Therapy. Nephrology Dialysis Transplantation, 30, 564-574. https://doi.org/10.1093/ndt/gfu233
[23]	Wang, W., Zolty, E., Falk, S., et al.（2006）Pentoxifylline Protects against Endotoxin-Induced Acute Renal Failure in Mice. American Journal of Physiology Renalal Physiology, 291, F1090-F1095. https://doi.org/10.1152/ajprenal.00517.2005
[24]	Oguz, E., Yilmaz, Z., Ozbilge, H., et al. (2015) Effects of Melatonin on the Serum Levels of Pro-Inflammatory Cytokines and Tissue Injury after Renal Ischemia Reperfusion in Rats. Renal Failure, 37, 318-322. https://doi.org/10.3109/0886022X.2014.991263
[25]	Newstead, C.G., Lamb, W.R., Brenchley, P.E. and Short, C.D. (1993) Serum and Urine IL-6 and TNF-α in Renal Transplant Recipients with Graft Dysfunction. Transplantation, 56, 831-835. https://doi.org/10.1097/00007890-199310000-00010
[26]	Cunningham, P.N., Dyanov, H.M., Park, P., et al. (2002) Acute Renal Failure in Endotoxemia Is Caused by TNF acting Directly on TNF Receptor-1 in Kidney. Journal of Immunology, 168, 5817-5823. https://doi.org/10.4049/jimmunol.168.11.5817
[27]	Huang, L., Zhang, R., Wu, J., et al. (2011) Increased Susceptibility to Acute Kidney Injury Due to Endoplasmic Reticulum Stress in Mice Lacking Tumor Necrosis Factor-α and Its Receptor 1. Kidney International, 79, 613-623. https://doi.org/10.1038/ki.2010.469
[28]	Vielhauer, V., Stavrakis, G. and Mayadas, T.N. (2005) Renal Cell-Expressed TNF Receptor 2, Not Receptor 1, Is Essential for the Development of Glomerulonephritis. Journal of Clinical Investigation, 115, 1199-1209. https://doi.org/10.1172/JCI200523348
[29]	Fritsch, J., Zingler, P., Särchen, V., Heck, A.L. and Schütze, S. (2017) Role of Ubiquitination and Proteolysis in the Regulation of Pro- and Anti-Apoptotic TNF-R1 Signaling. Biochimicaet Biophysica Acta Molecular Cell Research, 1864, 2138-2146.
[30]	Mulay, S.R., Desai, J., Kumar, S.V., et al. (2016) Cytotoxicity of Crystals Involves RIPK3-MLKL Mediated Necroptosis. Nature Communications, 7, Article No. 10274. https://doi.org/10.1038/ncomms10274
[31]	de Jesus Soares, T., Costa, R.S., Balbi, A.P. and Coimbra, T.M. (2006) Inhibition of Nuclear Factor-κB Activation Reduces Glycerol-Induced Renal Injury. Journal of Nephrology, 19, 439-448.
[32]	Stenvinkel, P., Ketteler, M., Johnson, R.J., et al. (2005) IL-10, IL-6 and TNF-α: Central Factors in the Altered Cytokine Network of Uremia the Good, the Bad, and the Ugly. Kidney International, 67, 1216-1233. https://doi.org/10.1111/j.1523-1755.2005.00200.x
[33]	Nechemia-Arbely, Y., Barkan, D., Pizov, G., et al. (2008) IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury. Journal of American Society of Nephrology, 19, 1106-1115. https://doi.org/10.1681/ASN.2007070744
[34]	van der Poll, T., Levi, M., Hack, C.E., et al. (1994) Elimination of Interleukin 6 Attenuates Coagulation Activation in Experimental Endotoxemia in Chimpanzees. Journal of Experimental Medicine, 179, 1253-1259. https://doi.org/10.1084/jem.179.4.1253
[35]	Yamada, Y. and Fausto, N. (1998) Deficient Liver Regeneration after Carbon Tetrachloride Injury in Mice Lacking Type 1 but Not Type 2 Tumor Necrosis Factor Receptor. American Journal of Pathology, 152, 1577-1589.
[36]	Ma, Y., Cheng, Q., Wang, E., et al. (2015) Inhibiting Tumor Necrosis Factor-α Signaling Attenuates Postoperative Cognitive Dysfunction in Aged Rats. Molecular Medicine Reports, 12, 3095-3100. https://doi.org/10.3892/mmr.2015.3744

Full-Text